Follicular conjunctivitis in dogs

Objective: To evaluate the incidence, clinical features, treatment, and outcome of canine follicular conjunctivitis (CFC). Procedure: Medical records of dogs diagnosed with CFC were reviewed. Data recorded included signalment, duration of clinical signs and treatment details prior to presentation, c...

Descripción completa

Detalles Bibliográficos
Autores: Cerrada, Irene|||0000-0002-0665-0202, Leiva Repiso, Marta|||0000-0003-2378-0946, Vilao Cardoso, Rita|||0000-0002-6513-0397, Peña Gimenez, Maria Teresa|||0000-0001-8809-5566, Ríos, José|||0000-0002-0716-8784
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:285873
Acceso en línea:https://ddd.uab.cat/record/285873
https://dx.doi.org/urn:doi:10.1111/vop.13155
Access Level:acceso abierto
Palabra clave:Allergic conjunctivitis
Atopy
Follicles
Papillae
Self-limiting conjunctivitis
Vernal conjunctivitis
Descripción
Sumario:Objective: To evaluate the incidence, clinical features, treatment, and outcome of canine follicular conjunctivitis (CFC). Procedure: Medical records of dogs diagnosed with CFC were reviewed. Data recorded included signalment, duration of clinical signs and treatment details prior to presentation, concurrent ocular/systemic diseases, ocular clinical signs, cytology, treatment, follow-up, and outcome. Blepharospasm, signs of self-trauma, hyperemia, chemosis, ocular discharge, and follicle location and severity (0.5-4) were retrospectively evaluated. Based on severity, treatment consisted of topical 0.1% diclofenac or 0.1% dexamethasone sodium eyedrops. Dogs were classified into young (YD < 18 months) and adult (AD ≥ 18 months). Results: One hundred and fifty-three dogs (276 eyes) were included in the study: 83YD (54%) and 70AD (46%). Males and bilateral disease were over-represented in both groups. Severity was associated with young age (p =.032) and bilaterality (p =.025), and not with dermatological diseases (p.